Wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

GIT COLOGY

Total questions: 27

Worksheet time: 14mins

Name
Class
Date
1.

Which of the following is a proton pump inhibitor (PPI)?


a)

A. Ranitidine

b)

B. Omeprazole

c)

C. Cimetidine

d)

D. Misoprostol

2.

The mechanism of action of omeprazole is:

a)

A. H₂ receptor blockade

b)

B. Inhibition of gastric proton pump (H⁺/K⁺ ATPase)

c)

C. Anticholinergic action

d)

D. Neutralization of gastric acid

3.

Which of the following drugs is a histamine H₂ receptor antagonist?


a)

A. Omeprazole

b)

B. Sucralfate

c)

C. Famotidine

d)

D. Misoprostol

4.

Cimetidine causes which of the following side effects?

a)

A. Hypoglycemia

b)

B. Gynecomastia

c)

C. Constipation

d)

D. Diarrhea

5.

Misoprostol is contraindicated in:

a)

A. Peptic ulcer disease

b)

B. Pregnancy

c)

C. NSAID-induced ulcers

d)

D. Zollinger–Ellison syndrome

6.


Sucralfate acts by:

a)

A. Inhibiting acid secretion

b)

B. Neutralizing acid

c)

C. Forming a protective barrier over ulcers

d)

D. Increasing gastric emptying

7.

Which antacid causes constipation?

a)

A. Magnesium hydroxide

b)

B. Aluminum hydroxide

c)

C. Sodium bicarbonate

d)

D. Calcium carbonate

8.

Which of the following increases gastric motility?

a)

A. Metoclopramide

b)

B. Loperamide

c)

C. Ondansetron

d)

D. Dicyclomine

9.
  1. The mechanism of action of metoclopramide involves:

a)

A. 5-HT₃ receptor blockade

b)

B. D₂ receptor blockade

c)

C. M₃ receptor stimulation

d)

D. H₁ receptor blockade

10.
  1. Domperidone differs from metoclopramide by:

a)

A. Not crossing the blood-brain barrier

b)

B. Having no prokinetic action

c)

C. Being an anticholinergic

d)

D. Causing sedation

11.

Which of the following is effective in motion sickness?

a)

A. Ondansetron

b)

B. Hyoscine

c)

C. Metoclopramide

d)

D. Domperidone

12.
  1. Loperamide acts by:

a)
  1. A. Increasing intestinal motility

b)
  1. B. Decreasing peristalsis via μ-opioid receptor activation

c)
  1. C. Stimulating chloride secretion

d)
  1. D. Blocking D₂ receptors

13.

Lactulose is used for:

a)

A. Diarrhea

b)

B. Peptic ulcer

c)

C. Hepatic encephalopathy

d)

D. Motion sickness

14.

Bulk-forming laxatives include:

a)

A. Castor oil

b)

B. Psyllium

c)

C. Bisacodyl

d)

D. Docusate sodium

15.
  1. The mainstay of therapy for Helicobacter pylori infection is:

a)

A. PPI + antibiotics

b)

B. H₂ blocker alone

c)

C. Antacid + sucralfate

d)

D. Misoprostol alone

16.
  1. Bismuth compounds act by:

a)

A. Inhibiting acid secretion

b)

B. Coating ulcers and killing H. pylori

c)

C. Stimulating mucus production

d)

D. Increasing gastric emptying

17.
  1. A patient with Zollinger–Ellison syndrome is best treated with:

a)
  1. A. Antacids

b)
  1. B. PPIs

c)
  1. C. H2 blockers

d)
  1. D. Anticholinergics

18.
  1. A patient on cimetidine develops gynecomastia because it:

a)

A. Stimulates prolactin

b)

B. Inhibits testosterone metabolism

c)

C. Inhibits estrogen metabolism

d)

D. Increases LH release

19.
  1. Which drug can cause rebound acid secretion on sudden withdrawal?

a)
  1. A. Ranitidine

b)
  1. B. Omeprazole

c)
  1. C. Cimetidine

d)
  1. D. Sucralfate

20.
  1. 20. Octreotide is an analogue of:

a)

A. Somatostatin

b)

B. Gastrin

c)

C. Secretin

d)

D. Cholecystokinin

21.
  1. A commonly used carminative agent is:

a)
  1. A. Peppermint oil

b)
  1. B. Omeprazole

c)
  1. C. Loperamide

d)
  1. D. Bisacodyl

22.
  1. A patient on prolonged PPI therapy may develop:

a)

A. Vitamin B12 deficiency

b)

B. Hypoglycemia

c)

C. Hyperkalemia

d)

D. Hypertension

23.
  1. Ursodeoxycholic acid decreases cholesterol in bile by:

a)

A. Inhibiting cholesterol synthesis

b)

B. Solubilizing cholesterol

c)

C. Blocking bile salt absorption

d)

D. Stimulating bile acid synthesis

24.
  1. Which drug decreases LES (lower esophageal sphincter) tone and worsens reflux?

a)
  1. A. Metoclopramide

b)
  1. B. Alcohol

c)
  1. C. Cisapride

d)
  1. D. Domperidone

25.

Rifaximin is used to treat:

a)

A. Traveler’s diarrhea

b)

B. GERD

c)

C. IBS with constipation

d)

D. Peptic ulcer

26.

Alosetron is used in:

a)

A. IBS with constipation

b)

B. IBS with diarrhea

c)

C. Ulcerative colitis

d)

D. Crohn’s disease

27.

Lubiprostone increases intestinal fluid secretion by activating:

a)

A. CFTR chloride channels

b)

B. Voltage-gated sodium channels

c)

C. Potassium channels

d)

D. 5-HT receptors